Rapid Micro Biosystems (NASDAQ:RPID – Get Free Report) was downgraded by research analysts at Roth Capital from a “buy” rating to a “neutral” rating in a report issued on Tuesday, MarketBeat reports. They presently have a $0.75 price target on the stock, down from their prior price target of $3.00. Roth Capital‘s price target indicates a potential upside of 1.68% from the company’s current price.
Several other equities research analysts have also issued reports on RPID. Weiss Ratings reiterated a “sell (d-)” rating on shares of Rapid Micro Biosystems in a research report on Thursday, October 15th. JPMorgan Chase & Co. set a $0.75 price target on shares of Rapid Micro Biosystems in a research note on Tuesday. One research analyst has rated the stock with a Buy rating, two have given a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat, Rapid Micro Biosystems presently has an average rating of “Hold” and an average target price of $1.81.
Get Our Latest Stock Report on Rapid Micro Biosystems
Rapid Micro Biosystems Price Performance
Rapid Micro Biosystems (NASDAQ:RPID – Get Free Report) last announced its earnings results on Monday, November 16th. The company reported ($0.22) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.21) by ($0.01). Rapid Micro Biosystems had a negative return on equity of 211.25% and a negative net margin of 138.24%. The business had revenue of $9.53 million during the quarter, compared to the consensus estimate of $9.85 million. On average, research analysts forecast that Rapid Micro Biosystems will post -0.94 earnings per share for the current fiscal year.
Institutional Investors Weigh In On Rapid Micro Biosystems
A number of large investors have recently added to or reduced their stakes in the company. Pekin Hardy Strauss Inc. bought a new stake in Rapid Micro Biosystems during the third quarter worth about $41,000. Temasek Holdings Private Ltd bought a new position in shares of Rapid Micro Biosystems during the 1st quarter valued at about $50,000. Bank of America Corp DE increased its position in shares of Rapid Micro Biosystems by 139.9% during the 1st quarter. Bank of America Corp DE now owns 31,014 shares of the company’s stock valued at $70,000 after purchasing an additional 18,085 shares during the last quarter. Dimensional Fund Advisors LP raised its holdings in shares of Rapid Micro Biosystems by 55.9% during the 1st quarter. Dimensional Fund Advisors LP now owns 87,589 shares of the company’s stock valued at $199,000 after buying an additional 31,407 shares in the last quarter. Finally, Renaissance Technologies LLC raised its holdings in shares of Rapid Micro Biosystems by 9.5% during the 1st quarter. Renaissance Technologies LLC now owns 126,617 shares of the company’s stock valued at $287,000 after buying an additional 10,990 shares in the last quarter. Hedge funds and other institutional investors own 52.60% of the company’s stock.
Rapid Micro Biosystems Company Profile
Rapid Micro Biosystems develops automated microbial detection systems for pharmaceutical, biotechnology and other life sciences manufacturers. Its products are designed to support quality-control testing by identifying and measuring microbial growth in manufacturing environments and products. The company’s Growth Direct platform combines laboratory instruments, consumables and software to automate microbial testing. Its applications include sterility testing, bioburden testing and environmental monitoring, helping manufacturers assess contamination during production.
Further Reading
- Five stocks we like better than Rapid Micro Biosystems
- Drilling for Yield in the Gulf: Chevron Drops Anchor in Deepwater
- TJX Stock Flashes a Strong Bullish Signal as Its $3 Billion Buyback Plan Takes Shape
- Viking’s Low-Water Miss Looks Like a Buy-the-Dip Opportunity
- Why Amazon Wants the Chips and Blackstone Wants the Buildings
Receive News & Ratings for Rapid Micro Biosystems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Rapid Micro Biosystems and related companies with MarketBeat.com's FREE daily email newsletter.
